News
Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...
20h
Stocktwits on MSNGSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish StanceGSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results